211 related articles for article (PubMed ID: 21284255)
21. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
22. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
Rawat S; Jain SK
Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
[TBL] [Abstract][Full Text] [Related]
23. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
Govindarajan R; Nagarsenker MS
J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
[TBL] [Abstract][Full Text] [Related]
24. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
Chang RK; Shojaei AH
Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
[TBL] [Abstract][Full Text] [Related]
26. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.
Tommasini S; Calabrò ML; Stancanelli R; Donato P; Costa C; Catania S; Villari V; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2005 Sep; 39(3-4):572-80. PubMed ID: 15985355
[TBL] [Abstract][Full Text] [Related]
27. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence enhancement of 1-napthol-5-sulfonate by forming inclusion complex with beta-cyclodextrin in aqueous solution.
Abdel-Shafi AA; Al-Shihry SS
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):533-7. PubMed ID: 19091626
[TBL] [Abstract][Full Text] [Related]
29. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
32. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
33. Estradiol sustained release from high affinity cyclodextrin hydrogels.
Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Rodriguez-Perez A; Concheiro A; Torres-Labandeira JJ
Eur J Pharm Biopharm; 2007 Apr; 66(1):55-62. PubMed ID: 17081737
[TBL] [Abstract][Full Text] [Related]
34. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 3. Bromhexine hydrochloride.
Ammar HO; el-Nahhas SA
Pharmazie; 1995 Jun; 50(6):408-10. PubMed ID: 7651977
[TBL] [Abstract][Full Text] [Related]
35. Inclusion complexation and photoprototropic behaviour of 3-amino-5-nitrobenzisothiazole with beta-cyclodextrin.
Rajamohan R; Nayaki SK; Swaminathan M
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Feb; 69(2):371-7. PubMed ID: 17604682
[TBL] [Abstract][Full Text] [Related]
36. Interaction between nitroheterocyclic compounds with beta-cyclodextrins: phase solubility and HPLC studies.
de Melo NF; Grillo R; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Aug; 47(4-5):865-9. PubMed ID: 18534804
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
Yuvaraja K; Khanam J
J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
[TBL] [Abstract][Full Text] [Related]
39. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.
Beig A; Miller JM; Dahan A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1293-9. PubMed ID: 23770429
[TBL] [Abstract][Full Text] [Related]
40. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
Doliwa A; Santoyo S; Ygartua P
Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
